Newer Birth Control Lasts Four Years: The Dangerous Nexplanon Implant

All hormonal birth control cause abortion of the developing baby — they are abortifacients.

Dispelling the Myths Behind Conception, Contraception and Abortifacient Drugs – Dr. J.C. Wilke

Risks To Your Health

rod can move away from the arm and into the lung:
This will kill you.


ectopic pregnancy:  developing baby smothered to death inside mother’s Fallopian tube; mother could bleed to death.  A
developing baby can also be found growing in other organs.

blood clots that can kill you:   Video about Deep Vein Thrombosis


“Danger In The Ring:  Lethal Contraceptive.” – Nuvaring

“Portrait of A Killer” – Nuvaring Contraceptive

The Victims
These are only some of the women who have been harmed or died while using NuvaRing.  Nuvaring truth

migration of the implant from arm to other place

FDA’s Medwatch Program Releases Nexplanon Safety Warning

After conducting a comprehensive investigation, the FDA released its latest safety warning regarding Nexplanon implants in March 2016.  The FDA warned of migration of the Nexplanon implant within the arm from the insertion site, which may be related to insertion of the implant deeper than is advised.  According to the FDA, the implant could migrate within the vessels of the arm, to the chest wall, and even to the pulmonary artery, which, it says, could also be related to deep insertions or intravascular insertion.  In cases where severe migration of the Nexplanon implant has occurred, surgical procedures may be needed to remove the device.

Nexplanon Lawsuit.

Clinicians who provide contraceptive services should, however, be aware that Implanon (now Nexplanon) may on occasion show up in unexpected locations that are far removed from the site of insertion.

Adverse Reaction To Nexplanon:  REPEAT INFECTIONS

SUMMARY.  The patient had the rod implanted by a physician.  The healing wound was traumatized after her arm was grabbed.  Following this incident the implant site became painful and bruised. This progressed to eventually becoming red and swollen with some purulent discharge. The patient was treated with a week’s course of flucloxacillin, which resulted in clinical improvement. However, the wound once again became red and painful with purulent discharge and she was treated with a further course of flucloxacillin. At this point the patient was treated with a 10-day course of clarithromycin and a swab of the site was taken. The swab result showed scanty growth of Staphylococcus aureus only and was negative for methicillin-resistant Staphylococcus aureus (MRSA). Again, there was clinical improvement with antibiotics.

You’re Only A Statistic in the Brave New World


Fertility and Sterility Journal

New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services

After decades of having the developed world’s highest rates of unintended pregnancy, the United States finally shows signs of improvement. This progress is likely due in large part to increased use of highly effective long-acting reversible methods of contraception. These methods can be placed and do not require any maintenance to provide years of contraception as effective as sterilization. Upon removal, fertility returns to baseline rates. This article addresses advances in both software—improved use and elimination of barriers to provide these methods; and hardware—novel delivery systems and devices.

Pregnancy is treated like a disease and must be prevented at all costs to the mother’s health.

Long-Acting Reversible Contraceptive implants were developed to depopulate the Third World.  Now, our daughters are given them.

Trends in Long-acting Reversible Contraception Use Among U.S. Women Aged 15–44.  Centers for Disease Control.

After declining from the early 1980s through 2002, use of long-acting reversible contraception has increased over the last decade. Women aged 25–34 and women who have already had a child continue to use LARCs at the highest rates as their current contraceptive methods; additionally, larger percent increases in LARC use have occurred more recently among young women (aged 15–24) and women who have not given birth. Although sharp increases in use occurred among non-Hispanic black women between 2002 and 2006–2010, the rate of increase has slowed through the 2011–2013 time period. LARC use more than doubled among Hispanic and non-Hispanic white women in the most recent time periods. Non-Hispanic white women, who have historically used LARCs at the lowest rate, had a rate of use similar to Hispanic women in 2011–2013.

Long-acting reversible contraception has demonstrated greater efficacy in preventing unintended pregnancy among all women compared with other contraceptive methods, including the oral contraceptive pill and the transdermal patch (2,3). In addition, recent research has demonstrated that women opt for long-acting methods as their contraceptive method of choice when informed about these options (4); however, other research has demonstrated that barriers to LARC administration and use still remain (5,6).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

The FDA released Nexplanon BEFORE the drug trials were completed.  As you can see, the FDA wants users of the drug to contact them to report side effects!  It hasn’t been fully tested!  This means that drug is unsafe to use!


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s